Joel Greenblatt · Magic Formula: alta rentabilidad del capital a un EV/EBIT bajo
Is Arbutus Biopharma Corporation (ABUS) a Joel Greenblatt Stock?
High-quality business at a cheap price, strong Magic Formula fit.
100/100
Encaja
3/5 criterios cumplidos
Los criterios de Joel Greenblatt, aplicados a ABUS
EBIT/EV yield ≥ 10%
clave-
ROIC ≥ 25%
clave56.7%
EV/EBIT ≤ 12
-
Gross margin ≥ 30%
100.0%
Cómo se valora ABUS en otras estrategias
Datos financieros en vivo
Cap. mercado
$682.08M
PER (TTM)
5.1x
ROIC (TTM)
56.72%
Margen bruto
99.98%
Otros análisis Joel Greenblatt
Preguntas frecuentes
What is ABUS's Joel Greenblatt fit score?
ABUS scores 100/100 on our Joel Greenblatt fit engine. High-quality business at a cheap price, strong Magic Formula fit.
Does Joel Greenblatt actually own ABUS?
Our score is computed from financial fundamentals against Joel Greenblatt's published criteria. We don't claim that Joel Greenblatt personally owns or recommends ABUS.
How often is this score updated?
ABUS's Joel Greenblatt fit score is recomputed daily from the latest TTM financials. The page below shows when it was last refreshed.
Herramienta educativa, no es asesoramiento financiero. Las puntuaciones se calculan a partir de datos financieros públicos contra los criterios publicados de cada estrategia de inversión. No afirmamos que Joel Greenblatt posea o recomiende ABUS personalmente.
